United States · FDA National Drug Code directory
Tizanidine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85742-032_5813a435-c3d7-46df-a197-52f4ba5d8924
- Product NDC
- 85742-032
- Form
- CAPSULE
- Composition / generic term
- Tizanidine hydrochloride
- Labeler
- Kanchan Healthcare Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171229
- Source listing expiry
- 20271231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 150 CAPSULE in 1 BOTTLE (85742-032-30) · 85742-032-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →